(Total Views: 195)
Posted On: 04/18/2024 4:58:55 PM
Post# of 5032
Improving Financial Performance [sources: 2023 Q1 and 2023 Annual Report]
Net Loss for 3 months ending March 31
Down to $251,686 in 2023 from $4,522,945 in 2022
Net Loss for 12 Months ending December 31
Down to $106,203 in 2023 from $1,995,219 in 2022
Net Loss for 3 months ending March 31
Down to $251,686 in 2023 from $4,522,945 in 2022
Net Loss for 12 Months ending December 31
Down to $106,203 in 2023 from $1,995,219 in 2022
(0)
(0)
"Per Ardua Ad Astra" - "Through Adversity To The Stars"
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
A very apposite motto for those who trade successfully in the OTC market..
All posts are my opinion - trade at your own risk.
